Établissement d'objectifs de performance analytique liés à la survenue d'événements (« outcomes »)

Translated title of the contribution: Establishment of outcome-related analytic performance goals

Georges G. Klee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background. Accrediting organizations require laboratories to establish analytic performance criteria that ensure their tests provide results of the high quality required for patient care. However, the procedures for instituting performance criteria that are directly linked to the needs of medical practice are not well established, and therefore alternative strategies often are used to create and implement surrogate performance standards. Content. We reviewed six approaches for establishing outcome-related analytic performance goals: (a) limits defined by regulations and external assessment programs, (b) limits based on biologic variation, (c) limits based on surveys of clinicians about their needs, (d) limits based on effects on guideline driven medical decisions, (e) limits based on analysis of patterns for ordering follow-up clinical tests, and (f) limits based on formal medical decision models. Performance criteria were tabulated for 12 common chemistry analytes and four routine hematology tests. Conclusions. There is no consensus currently about the preferred methods for establishing medically necessary analytic performance limits. The various methods reviewed give considerably different performance limits. The analytic performance limits claimed by a laboratory should correspond to those limits that can be reliably maintained based on validated QC monitoring systems. These limits generally are larger than the observed CVs and bias parameters collected for assay validation. There is a major need for increased communication among laboratorians and clinicians on this topic, especially when the analytic performance limits that can be consistently maintained by a laboratory are inconsistent with the expectations of health care providers.

Original languageFrench
Pages (from-to)139-150
Number of pages12
JournalAnnales de Biologie Clinique
Volume69
Issue number2
DOIs
StatePublished - Mar 2011

Fingerprint

Hematology
Health care
Health Personnel
Assays
Consensus
Patient Care
Communication
Organizations
Guidelines
Monitoring
Surveys and Questionnaires

Keywords

  • Analytical performance
  • Clinical chemistry
  • Outcome

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Établissement d'objectifs de performance analytique liés à la survenue d'événements (« outcomes »). / Klee, Georges G.

In: Annales de Biologie Clinique, Vol. 69, No. 2, 03.2011, p. 139-150.

Research output: Contribution to journalArticle

@article{be5ea31504b441ce96cc2f0b9691cd15,
title = "{\'E}tablissement d'objectifs de performance analytique li{\'e}s {\`a} la survenue d'{\'e}v{\'e}nements (« outcomes »)",
abstract = "Background. Accrediting organizations require laboratories to establish analytic performance criteria that ensure their tests provide results of the high quality required for patient care. However, the procedures for instituting performance criteria that are directly linked to the needs of medical practice are not well established, and therefore alternative strategies often are used to create and implement surrogate performance standards. Content. We reviewed six approaches for establishing outcome-related analytic performance goals: (a) limits defined by regulations and external assessment programs, (b) limits based on biologic variation, (c) limits based on surveys of clinicians about their needs, (d) limits based on effects on guideline driven medical decisions, (e) limits based on analysis of patterns for ordering follow-up clinical tests, and (f) limits based on formal medical decision models. Performance criteria were tabulated for 12 common chemistry analytes and four routine hematology tests. Conclusions. There is no consensus currently about the preferred methods for establishing medically necessary analytic performance limits. The various methods reviewed give considerably different performance limits. The analytic performance limits claimed by a laboratory should correspond to those limits that can be reliably maintained based on validated QC monitoring systems. These limits generally are larger than the observed CVs and bias parameters collected for assay validation. There is a major need for increased communication among laboratorians and clinicians on this topic, especially when the analytic performance limits that can be consistently maintained by a laboratory are inconsistent with the expectations of health care providers.",
keywords = "Analytical performance, Clinical chemistry, Outcome",
author = "Klee, {Georges G.}",
year = "2011",
month = "3",
doi = "10.1684/abc.2011.0541",
language = "French",
volume = "69",
pages = "139--150",
journal = "Annales de Biologie Clinique",
issn = "0003-3898",
publisher = "John Libbey Eurotext",
number = "2",

}

TY - JOUR

T1 - Établissement d'objectifs de performance analytique liés à la survenue d'événements (« outcomes »)

AU - Klee, Georges G.

PY - 2011/3

Y1 - 2011/3

N2 - Background. Accrediting organizations require laboratories to establish analytic performance criteria that ensure their tests provide results of the high quality required for patient care. However, the procedures for instituting performance criteria that are directly linked to the needs of medical practice are not well established, and therefore alternative strategies often are used to create and implement surrogate performance standards. Content. We reviewed six approaches for establishing outcome-related analytic performance goals: (a) limits defined by regulations and external assessment programs, (b) limits based on biologic variation, (c) limits based on surveys of clinicians about their needs, (d) limits based on effects on guideline driven medical decisions, (e) limits based on analysis of patterns for ordering follow-up clinical tests, and (f) limits based on formal medical decision models. Performance criteria were tabulated for 12 common chemistry analytes and four routine hematology tests. Conclusions. There is no consensus currently about the preferred methods for establishing medically necessary analytic performance limits. The various methods reviewed give considerably different performance limits. The analytic performance limits claimed by a laboratory should correspond to those limits that can be reliably maintained based on validated QC monitoring systems. These limits generally are larger than the observed CVs and bias parameters collected for assay validation. There is a major need for increased communication among laboratorians and clinicians on this topic, especially when the analytic performance limits that can be consistently maintained by a laboratory are inconsistent with the expectations of health care providers.

AB - Background. Accrediting organizations require laboratories to establish analytic performance criteria that ensure their tests provide results of the high quality required for patient care. However, the procedures for instituting performance criteria that are directly linked to the needs of medical practice are not well established, and therefore alternative strategies often are used to create and implement surrogate performance standards. Content. We reviewed six approaches for establishing outcome-related analytic performance goals: (a) limits defined by regulations and external assessment programs, (b) limits based on biologic variation, (c) limits based on surveys of clinicians about their needs, (d) limits based on effects on guideline driven medical decisions, (e) limits based on analysis of patterns for ordering follow-up clinical tests, and (f) limits based on formal medical decision models. Performance criteria were tabulated for 12 common chemistry analytes and four routine hematology tests. Conclusions. There is no consensus currently about the preferred methods for establishing medically necessary analytic performance limits. The various methods reviewed give considerably different performance limits. The analytic performance limits claimed by a laboratory should correspond to those limits that can be reliably maintained based on validated QC monitoring systems. These limits generally are larger than the observed CVs and bias parameters collected for assay validation. There is a major need for increased communication among laboratorians and clinicians on this topic, especially when the analytic performance limits that can be consistently maintained by a laboratory are inconsistent with the expectations of health care providers.

KW - Analytical performance

KW - Clinical chemistry

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=79953905683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953905683&partnerID=8YFLogxK

U2 - 10.1684/abc.2011.0541

DO - 10.1684/abc.2011.0541

M3 - Article

C2 - 21464006

AN - SCOPUS:79953905683

VL - 69

SP - 139

EP - 150

JO - Annales de Biologie Clinique

JF - Annales de Biologie Clinique

SN - 0003-3898

IS - 2

ER -